Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights From the GHAS Trial
doi 10.20944/preprints201911.0389.v1
Full Text
Open PDFAbstract
Available in full text
Date
November 30, 2019
Authors
Publisher
MDPI AG